These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29603832)

  • 41. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
    Oldfield EC; Keeffe EB
    Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
    Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC
    Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel.
    Chodick G; Green MS; Heymann AD; Rosenmann L; Shalev V
    Prev Med; 2007 Nov; 45(5):386-91. PubMed ID: 17599401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis A in Poland in 2012.
    Baumann-Popczyk A
    Przegl Epidemiol; 2014; 68(2):253-6, 361-2. PubMed ID: 25135510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of the single-dose immunization strategy against hepatitis A in Argentina.
    Vizzotti C; González J; Gentile A; Rearte A; Ramonet M; Cañero-Velasco MC; Pérez Carrega ME; Urueña A; Diosque M
    Pediatr Infect Dis J; 2014 Jan; 33(1):84-8. PubMed ID: 24352191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pre-travel advice, attitudes and hepatitis A and B vaccination rates among travellers from seven countries†.
    Heywood AE; Nothdurft H; Tessier D; Moodley M; Rombo L; Marano C; De Moerlooze L
    J Travel Med; 2016 Jul; 24(1):. PubMed ID: 27738112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation on the role of hepatitis A vaccine in the prevention and control of hepatitis A in Tianjin city].
    Zhang ZL; Zhu XJ; Ding YX; Xie XH; Gao ZG; Li YC; Zhang Y; Xia WD; Liu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):1000-3. PubMed ID: 18399149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B in Poland in 2014.
    Stępień M; Piwowarow K; Czarkowski MP
    Przegl Epidemiol; 2016; 70(2):231-241. PubMed ID: 27779839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surveillance for acute viral hepatitis--United States, 2005.
    Wasley A; Miller JT; Finelli L;
    MMWR Surveill Summ; 2007 Mar; 56(3):1-24. PubMed ID: 17363893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hepatitis A in Poland in 2009].
    Baumann-Popczyk A
    Przegl Epidemiol; 2011; 65(2):255-8. PubMed ID: 21913470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of hepatitis A and B vaccination programme in Germany.
    Szucs T
    Vaccine; 2000 Feb; 18 Suppl 1():S86-9. PubMed ID: 10683559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012.
    Levine H; Kopel E; Anis E; Givon-Lavi N; Dagan R
    Euro Surveill; 2015 Feb; 20(7):3-10. PubMed ID: 25719962
    [No Abstract]   [Full Text] [Related]  

  • 53. Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies.
    Cotter SM; Sansom S; Long T; Koch E; Kellerman S; Smith F; Averhoff F; Bell BP
    J Infect Dis; 2003 Apr; 187(8):1235-40. PubMed ID: 12696002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The changing gender differences in hepatitis a incidence in South Korea.
    Choe YJ; Son H
    Vaccine; 2020 Jan; 38(4):712-714. PubMed ID: 31787416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Epidemiological characteristics of hepatitis A and hepatitis E in different periods of vaccination in China, 2004-2015].
    Sun XJ; Wang FZ; Zheng H; Miao N; Wang HQ; Yin ZD; Zhang GM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Oct; 39(10):1351-1355. PubMed ID: 30453436
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of mass vaccination programmes: the experience of Hepatitis A in Catalonia].
    Oviedo M; Muñoz P; Domínguez A; Carmona G; Batalla J; Borras E; Jansà JM
    Rev Esp Salud Publica; 2009; 83(5):697-709. PubMed ID: 20111818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis A in Poland in 2011.
    Baumann-Popczyk A
    Przegl Epidemiol; 2013; 67(2):235-8, 347-8. PubMed ID: 24040724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis A in Poland in 2014.
    Polański P
    Przegl Epidemiol; 2016; 70(2):225-230. PubMed ID: 27779838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Universal hepatitis A vaccination in Brazil: analysis of vaccination coverage and incidence five years after program implementation.
    Brito WI; Souto FJD
    Rev Bras Epidemiol; 2020; 23():e200073. PubMed ID: 32638856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.